
Low-dose vitamin E shows promise in repairing fatty liver damage
A multicenter trial found that taking 300 mg/day of vitamin E improved liver tissue in adults with metabolic dysfunction–associated steatohepatitis (MASH), with about 29.3% showing histological improvement versus 14.1% on placebo, and noninvasive scans suggesting reduced liver stiffness. The lower dose, compared with earlier high-dose studies, still yielded benefits, but the results are modest and not yet generalizable to all patients. Current vitamin E guidance remains cautious, recommending use only in select non-diabetic adults under supervision, alongside lifestyle changes. More diverse, larger studies are needed to confirm durability and determine how vitamin E fits with diet and other treatments.













